Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-85.51	62.85	433.67
Graham Fair Price	-33.05	17.39	25.97
PEG	21.58	-0.30	0.25
Price/Book	36.67	2.08	1.52
Price/Cash Flow	-752.16	-585.91	-68.76
Prices/Earnings	191.96	42.32	-14.49
Price/Sales	20.45	6.61	5.49
Price/FCF	-752.16	-585.91	-68.76
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	78.44	0.29	0.16
Operating Margin	14.02	0.08	-0.07
ROA	-51.81	< 0.005	-0.01
ROE	-0.03	0.01	-53.19
ROIC	-0.01	0.01	-8.31
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.07	0.09	-20.76
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.65	2.30	255.13
EPS QOQ	0.58	1.39	140.14
FCF QOQ	0.68	0.84	23.84
Revenue QOQ	0.10	0.14	36.69
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	113.95	117.81	3.39
Days Sales Outstanding (DSO)	45.21	46.86	3.66
Inventory Turnover	0.79	0.76	-3.28
Debt/Capitalization	0.43	0.41	-4.63
Quick Ratio	0.85	0.91	6.83
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	33.81	33.09	-2.15
Cash	7.67	5.70	-25.66
Capex	-0.46	-0.29	37.03
Free Cash Flow	-0.75	-0.12	84.31
Revenue	9.37	10.40	11.03
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.67	1.86	11.27
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	113.69	12.85	-88.69
Naive Interpretation	Member

06 - Financial Health · Weak

Rating